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ABSTRACT
The objective of the current work is to develop novel procedures for the analysis of functional data
and apply them for investigation of gender disparity in survival of lung cancer patients. In partic-
ular, we use the time-dependent Cox proportional hazards model where the clinical information is
incorporated via time-independent covariates, and the current age is modeled using its expansion
over wavelet basis functions. We developed computer algorithms and applied them to the data
set which is derived from Florida Cancer Data depository data set (all personal information which
allows to identify patients was eliminated). We also studied the problem of estimation of a con-
tinuous matrix-variate function of low rank. We have constructed an estimator of such function
using its basis expansion and subsequent solution of an optimization problem with the Schatten-
norm penalty. We derive an oracle inequality for the constructed estimator, study its properties via
simulations and apply the procedure to analysis of Dynamic Contrast medical imaging data.
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CHAPTER 1: INTRODUCTION
The lung cancer is the number one killer for men and women in USA, since year 1987 when it
surpassed the breast cancer killing rate in women [1]. The lung cancer causes more death than 3
next most dangerous cancers combained: breasts, colorectal and pancreas. The predicted death rate
of lung cancer in year 2014 is almost 160 millions. American Lung Cancer Assosiation reports that
the number of deaths due to lung cancer has increased approximately 4.3 percent between 1999
and 2010 from 152,156 to 158,318. The number of lung cancer deaths among men has reached
a plateau but the number is still rising among women. In 2010, there were 87,740 deaths due to
lung cancer in men and 70,578 in women. The age-adjusted death rate for lung cancer is higher
for men (60.3 per 100,000 persons) than for women (38.1 per 100,000 persons). The rate of new
lung cancer cases (incidence) over the past 36 years has dropped for men (24% decrease), while it
has risen for women (100% increase). In 1975, rates were low for women, but rising for both men
and women. In 1984, the rate of new cases for men peaked (102.1 per 100,000) and then began
declining. The rate of new cases for women increased further, did not peak until 1998 (52.9 per
100,000), and has now started to decline
Most studies have reported that women receive lung cancer diagnoses at a younger median age,
suggesting that they may have an increased susceptibility to the development of lung cancer. Hen-
schke and Miettinen [16] provided evidence that, for a given level of smoking, more women than
men develop lung cancer, using baseline CT screening for lung cancer. However, not all studies
support this observation and the effects of gender on the lung cancer risk associated with tobacco
use remains incompletely resolved [10].
The initial objective of current work was to determine whether observed gender disparity in sur-
vival of lung cancer patients can be explained, at least in part, by hormonal differences between
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males and females. Gender differences in lung cancer susceptibility, presentation and survival may
result from estrogen involvement. In particular, our hypothesis was that females with stage 0, 1 or 2
lung cancer exhibit unusual survival patterns around menopausal age when hormonal instabilities
become more pronounced. This conjecture is supported by preliminary data analysis of Florida
cancer data base which contains data for cancer patients in the state of Florida between years 1986
and 2005.
Survival analylis is the tool of choise in our investigation. This branch of statistical science deals
with finding and analysing relationships between some univariate lifetime variable, which is often
referred to as failure time and some set of explanatory variables. To carry out our investigation,
we develop a Cox regression model with current age-dependent covariates, which in turn were
created as functional expansion of unknow hazard function. It is well known that survival of a lung
cancer patient is strongly correlated with age. To account for this fact, patients are usually grouped
by their age at diagnosis and the age group numbers act as categorical covariates. This approach
works very well for more advanced stages of cancer where survival of a patient beyond 2-3 years
is very unlikely. However, for early stages of cancer where average survival time is much longer, a
patient might go into remission which is interrupted by an age-dependent event (say, menopause).
In order to investigate how survival rates depend on the current age of a patient, one needs to
include it into the model together with survival time. Since the current age, the survival time and
the age of diagnosis are functionally related, we represent the age dependent component of the
hazard function via its expansion over a wavelet basis, in particular, Haar and Mexican hat wavelet
bases [15].
The rest of the dissertation is organized as follows. Chapter 2 provides background information.
In particular, section 2.1 introduces main notions, such as censoring and truncation, and main
techniques in survival analysis, such as the Kaplan-Meier estimator, the Cox proportional hazard
model, and accelerated failure time model. Section 2.2.1 reviews wavelet techniques. Section
2
3.3 presents a preliminary study of gender and age-dependent survival rates. In particular, Section
3.3.1 introduces wavelet model for hazard and survival functtions which allows to take into account
current age of a patient while analyzing survival rates. Section 3.3.2 contains comprehensive
description of the data. Section 3.3.4 contains results of our study. Section 4 contains father
developing of the functional data analysis applied to tensor data. Chapter 4 devoted to another
interesting topic - denoising of the medical data. Finally, Section 5.2 concludes the paper with the
proposal on future work.
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CHAPTER 2: BACKGROUND INFORMATION
2.1 Survival analysis
Survival analysis deals with the death of biological organisms, failure in mechanical systems or
generally with timing of events, i.e., the time elapsed from a specific time origin until the event
occurs. In practice an event time could be, for example, the time until tumor recurrence( length
of remission, the time until a car engine fails, time of death from a particular disease, time for
unemployed to find a job, etc. One can see that there is a possibility that a time-to-event will not
be observed due to many causes, one of them is that the event has not occur during the time of
observation. We call the case of incomplete observation - censoring. The necessity of designing
methods for analysis that accommodate censoring is the primary reason for developing models and
procedures for time-to-event data. Prior to development of these procedures , incomplete data were
treated as missing data and omitted from the analysis. This resulted in the loss of information and
introducing bias in the estimated quantities, which lowers efficacy of the studies.
2.1.1 Basic definitions
We are following below [28] Assume for the moment that we know the distribution function of
events in interest. Let F (·) denote the distribution function with corresponding probability den-
sity function f(·), let T denote a non negative random variable representing the lifetimes of indi-
viduals in some population. Then the probability that an individual survives till time t is given by
4
the survival function:




The hazard function specifies the instantaneous rate of failure at T = t given that the individual
survived up to time t and is defined as:
h(t) = lim
∆t→0+






The hazard function is also referred to as mortality rate, it can assume values in [0,∞).It is easily










h(x) dx = − log(S(t)) (2.3)
Therefore knowing the hazard function is enough to find the distribution function F (t) and proba-
bility density function f(t) as:
F (t) = 1− exp(−
∫ t
0




There are couple of useful formulas one can easily derive from the above given information and
basis principals: The well known mean value of the random variable T , E(T ) can be expressed
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Another interesting function is the mean residual life at time T , denoted by MRL(T ).For indi-
viduals of age T , it is the expected remaining lifetime, defined as:






It is clear that MRL is the area under survival curve to the right of T divided by S(T ).
2.1.1.1 Censoring and truncation
There are three main types of censoring: right, left and interval censoring. The right censoring
is the one that occurs most often. This type arises when we do not observe the failure time due
to terminating of the experiment or due to withdrawal of the subject from observation. It is very




1, if T ≤ tc
0, if tc < T
(2.5)
Thus, in every survival experiment we observe an iid pairs (Yi, δi), where
Yi =

Ti if T ≤ tc
tc, if tc < T
(2.6)
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Hence, for the n observations we can construct a joint probability distribution function assuming
we know p.d.f. for the one observation f(yi). That joint p.d.f. is called the likelihood and is







Another type of censoring is the so called left censoring when the event of interest already occurred
at the beginning of observation time, but it is not known when exactly. The left censoring is much
rare than right one, the examples of the left censoring include:
• the moment of being infected with a sexually-transmitted disease
• time at which teenagers begin to drink alcohol
Finally there is one more type of censoring: interval censoring. The interval censoring occurs if the
exact time when event occurs is not known precisely, but an interval bounding this time is known.
For example, a study of a light bulb life where we screw bulbs into sockets and then check whether
they are on or off once a day is the example of the interval censoring with the interval one day.
One need to distinguish censoring from truncation. Truncation is a procedure where a condition
other than the main event of interest is used to screen patients. Here, we cite an example of right
truncation [7]. Early in the AIDS outbreak, patients with AIDS were recruited to study the time
from being infected with HIV to development of AIDS. At the time of the study, many people were
infected with HIV but had not yet developed symptoms of AIDS.
In the research below we shall be concerned only with right censored data.
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Table 2.1: Hypothetical drug study (+ indicates a censored value)
Group Length of complete remission(weeks)
Treated 6 13 13+ 15+ 19 19+ 22 25+ 30 44 49+ 99 112+
Nontreated 5 8 9+ 11 13+ 18 18 19+ 25 30 37 44 51
2.1.1.2 Nonparametric methods
In real life situation it is a rare case when the distribution function is known a priory. In order
to conduct statistical inference one needs methods that make no assumptions on the shape of the
underlying distribution function, the so called non parametric methods. It is well understood that
non parametric methods are not a panacea -all they are based on some kind of assumptions. The
goal on non parametric methods is to retrieve as much information as possible from the given data.
We will review here three main non parametric methods ranged by difficulty.
2.1.1.2.1 The Kaplan-Meier estimator
Consider the hypothetical data for cancer remission :
The naive approach would be to treat the data as if there are no censored observations. The empir-
ical survival function(esf) denoted as Sn(t) is defined as:
Sn(t) =





As we mentioned above, the attempt to ignore censoring leads to biased estimation. To account for
the censoring Kaplan and Meier introduced the product-limit estimator is their seminal paper [23].
The following notation will be used:
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• ni -the number of patients alive and not censored just before yi
• di - the number of patients died at time yi
• pi = P (T > yi|T > yi−1)
• qi = 1− pi









Figure 2.1. shows the result of application Kaplan-Meier estimator to our toy example data in Table
2.1. One can see that ignoring censored data indeed introduces bias in estimation of the survival
function.
Figure 2.1: Comparison of naive approach (ESF) and Kaplan-Meier (K-M) estimators for the
survival data (2.1)
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2.1.1.2.2 Cox-Proportional Hazard Model
The Cox-Proportional Hazard model, the Cox model for short, is neither parametric, nor non-
parametric model, it is a semi-parametric model. Cox model offers association of hazard function
with covariates and, therefore, provides a very, versatile tool for survival analysis. It assumes that
the hazard function is of the form
h(t|x) = h0(t)ex
Tβ, (2.7)
where x(t) = (x1(t), ..., xn(t)) is a n-dimensional measurable covariate and β is the n-dimensional
regression parameter. Let us consider two sets of predictors from the same model: X and X∗.








(X∗ − X) β
]
. (2.8)
The fact that hazard ratio is independent on time, is the manifestation of the Cox Model and is
responsible for the name- Proportional Hazard.
Let T , C and x be, respectively, the survival time, the censoring time and their associated covari-
ates. Correspondingly, let Y as in (2.6) be the observed time and δ = I(T ≤ C) be the censoring
indicator as in (2.5). It is assumed that T and C are conditionally independent given x and the
censoring mechanism is noninformative. When the observed data (xi, Yi, δi), i = 1, ..., n, forms an
















where the sets of indices c and u refer to the censored and uncensored data respectively, and
S̄(Yi|xi), h(Yi|xi) and f(Yi|xi) are the conditional survival function, conditional hazard function
and the conditional density function of T given x.
In order to present the likelihood function of Cox’s proportional hazards model explicitly, more
notation is needed. Let t01 < · · · < t0N denote the ordered observed failure times. Let (j) provide
the label for the item falling at t0j , so that the covariates associated withN failures are x(1), . . . , x(N).
Let Rj denote the risk set right before the time t0j .
Rj =
{
i : Yi ≥ t0j
}
.











h0(t) dt is the cumulative baseline hazard function. In the Cox proportional
hazard model, the baseline is unknown and has not been parametrized. Consider the ”least infor-
mative” non-parametric modelling forH0(·), in whichH0(t) has a possible jump hj at the observed








hjI(i ∈ Rj) (2.10)
Using (2.10), the logarithm of likelihood of (2.9) becomes
N∑
j=1






























where d is the dimension of β. The penalized likelihood estimate of β is derived by maximizing
(2.12) with respect to β. With a proper choice of pλ, many of the estimated coefficients will be zero
and hence, the corresponding variables do not appear in the model. This achieves the objectives of
the variable selection. To justify the better models, various criteria are used, the most popular of
them isAkaike Information criterion(AIC), see e.g. [28].
2.1.1.2.3 Cox Model for Time-Dependent Variables
The great advantage of the Cox model it is its flexibility and expandability. The case of time-
dependent covariates is the example of the above statement. Given a situation involving both
time-independent and time-dependent predictor variables, we can write an extended Cox model
that incorporates both types as shown below:











(see, e.g. [24]). Equation (2.13) is similar to the equation (2.7) in a sense that both contain base-
line function h0(t). Exponential part in equation (2.13) contains, however, both time-independent
predictors, as denoted by Xi and time-dependent predictors denoted by Xj . To assess values of δj
and coefficients βi, the maximum likelihood estimation (MLE) procedure is used, which assumes
that the hazard at time t depends on the value of Xi(t) at the same time t. However, it is possible
to modify the definition of the time-dependent covariates to allow for a ”lag-time” effect. MLE’s
are obtained by maximizing a (partial) likelihood function. However, the computations for the
extended Cox model turn out to be more complicated than for the Cox model (2.7), because the
risk sets used to form the likelihood function are more complicated with time-dependent variables.
The apparent simplicity of the model (2.13) has its drawbacks, the most serious of which is the
time dependence of the hazard ratio.
2.1.1.2.4 Cox Likelihood maximization
Let’s start with non-penalized version of Cox likelihood. The goal is to find vector ~β where:











where X is the matrix of covariates, which can be time dependent. Most common algorithm to
solve the maximization problem is the Newton-Raphson algorithm. Starting with some initial
guess β0 it proceeds iteratively computing:
βi+1 = βi −H−1(βi)G(βi) (2.14)
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where G(·) is the gradient vector of log-likelihood and H(·) is the matrix of second derivatives of


































The simple observation brought by [37] will allow us to change notation and to simplify equations
above. Since we have our design matrix sorted according to survival times, each event time j




as probability p(j)i from probability distribution P
j . Taking that into















〈X·,k〉(j) 〈X·,m〉(j) − 〈X·,kX·,m〉(j)
]
where 〈·〉(j) is the average over distribution created from the risk set Rj . Properties of that distri-
bution will be described below.
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2.1.1.2.5 Accelerated failure time model
Accelerated failure time model is a fully parametric approach. The model assumes that response
is log-linear with respect to covariates, i.e.:
Y = log(T ) = ~Xβ + Z (2.17)
where Z is a random variable which does not appear in the inference. distribution. Then for
T ∗ = expZ one has
T = exp(Y ) = T ∗ exp( ~Xβ) (2.18)
Assuming that T ∗ and T have pdf’s f ∗(·) and f(·) cdf’s F ∗(·) and F (·), respectively, define func-
tion g(·) such that T = g(T ∗). Simple algebra yields:
f(t) = P (T < t) = P (T ∗ < g−1(t)) = F ∗(g−1),
hence,
f(t) = f ∗(g−1(t))
∣∣∣∣∂g−1(t)∂t
∣∣∣∣ .
If T ∗ has the hazard function h∗0(t





Using comparison of equation (2.18) with definition of g(t), the derivative can be evaluated and
the following expression for the hazard function obtained:






The equation (2.19) makes apparent the word ”accelerated” in the name of the model.
2.2 Functional Data Analysis
Functional Data Analysis (FDA) is a way to represent discrete data by continuous functions (see
e.g. see [21]) with intention to achieve the following goals:
• reduce the noise
• find the underlying pattern
• predict the outcomes for the new data
Functional Data Analysis tends to treat discrete data as functional entities (see e.g. [21]) by as-
suming the existence of the intrinsic structure of the data. In practice, functional data are observed
discretely as pairs (tj, yj) where
yj = f(tj) + εj, j = 1, · · · , n.
is possibly blurred by the measurement errors. We usually wish to declare function f(t) as smooth,
i.e., the pair of adjacent data values, yj and yj+1 are linked together and unlikely to be too different
from each other. If this property doesn’t hold there would be nothing much to be gained by treating
the data as functional rather than just multivariate. Assuming that the observed data values are
values of some function, the first task is to convert these values to a function, computable for
any sensible argument. Due to the error, one can not use an interpolation algorithm and need to
employ some kind of smoothing technique. The basic ideas of FDA can be described as follows.
Consider the model: fi(x) =
∑N
i=1 φi(x)ci. The system {φ(·)j}
∞
1 is called the basis system for
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f . A basis function system is a set of known functions that are linearly independent and can
approximate arbitrary well any function by taking a weighted sum of a sufficiently large number
of these functions. The most trivial basis function system would be the collection of monomials:
1, t, t2, t3, · · · , tn, · · · .
. In spite of its simplicity, the system above is used very rarely in real application of FDA due to
the very high value of the conditional number of the transformation matrix and thus difficulties to
invert the transformation. Therefore it is important to select a right basis system. Below we discuss
the three most popular bases: the Fourier basis, the B-spline basis and the wavelet basis.




– natural representation of periodic functions
– exelent from the computational point of view is the sample data are equidistant.
– can be problematic forrepresentation of the non-periodic functions.
The best known expansion, the basis is periodic and the period is usually equal to the length
of interval over which the observation took place. Fourier series generally yields expan-
sions which are uniformly smooth, but they are inappropriate to some degree for data with
discontinuities in the function itself or in low order derivatives.
• B-splines.
Consider with a partition of some interval (a, b) We call that partition a knot sequence {ti}.
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Thus the B-splines of the first order will be the indicator function for that partition, i.e. :
Bi1(x) =






iBi1(t) = 1, for all t. Starting from the first order, all following
orders of B-splines obtained recursively:






, if t 6= ti+k−1
0, otherwise.
B-splines constitute a common choice for non-periodic data. To define a spline one needs to
divide the interval, over which a function is to be approximated, into L subintervals . Over
each subinterval, a spline is a polynomial of a specified order m. Adjacent polynomials joint
up smoothly at the breakpoints, moreover, derivatives up to order (m − 2) also match up.
The advantages of the B-splines are:
– good for non cyclic data
– very effective computationally
– tricky knot placement can be a drawback of B-splines
• Wavelets
The wavelet expansion of a function f gives a multiresolution analysis, providing informa-
tion on a sequence of degrees of locality. It copes very well with discontinuities or rapid




We are following below [8]. The fundamental idea behind wavelets is to analyse a function accord-
ing to scale and location simultaneously. It introduces univariate function ψ, defined on R ,which,
when subjected to the fundamental operations of shifts and dyadic dilation, yields an orthogonal
basis of L2(R). That is, the functions
ψj,k(·) = 2j/2ψ(2j · −k), j, k ∈ Z (2.22)
form a complete orthogonal basis of L2(R). One can view wavelet as a ”bump” with a compact
support(though not necessary). Dilation squeezes or expands the ”bump” and translation shits it.
Thus ψj,k is a scaled version of ψ centered at the dyadic integer k/2j . The large value of j -the
smaller support of ψj,k.
The requirement that the set {ψj,k}j,k∈Z forms an orthonormal system means that any function





Wavelets corresponding to small values of j contribute to broad resolution of f ; those correspond-
ing to larger values of j give finer details. The known advantage of using wavelet basis versus other
type of bases is that it accommodates jump discontinuities in the underlying function. Wavelets
allow one to investigate behaviour of a spatially inhomogeneous function without any assumptions
on the size or location of the intervals of smooth (or stable) behaviour. The decomposition (2.23)
is analogous to the Fourier decomposition of a function f in terms of complex exponents, but there
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is important differences:
• The exponential functions have global support. Thus, all terms in the Fourier decomposition
contribute to the value of f at a point x. On the other hand, wavelets usually either have
compact supports or have fast decay at infinity. Thus, only the terms in (2.23) corresponding
to ψj,k with k/2j near x make a large contribution at x. In this sense, representation (2.23)
is local.
• The coefficients in wavelet decompositions usually encode all information needed to tell
whether f is in a smoothness space, such as the Sobolev and Besov spaces. For example, if








In this work we have used only two types of wavelets: Haar and Mexican Hat wavelets. We give
father details below.
2.2.1.1 The Haar Wavelets
The Haar functions are known since 1910. They are the most elementary wavelets. While they
have many drawbacks, the main one being lack of smoothness, they illustrate, in the most direct
way, some of the main features of wavelet decompositions. For this reason, we shall consider in
some detail the properties that make them suitable for numerical applications. We will follow here
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[15]. Consider the following subspace V0 of L2(R):
V0 = {f ∈ L2(R) : f is constant on (k, k + 1] , k ∈ Z}
Thus,





φ(x) = I{x ∈ (0, 1]} =
 1, x ∈ (0, 1]0, x /∈ (0, 1] (2.24)
The translated function denote as φ0,k = φ(x−k), k ∈ Z. Applying dilation, define a new linear
subspace of L2(R) by
V1 = {h(x) = f(2x) : f ∈ V0}
It is clear that V1 ⊂ V0. Upon normalization the system of basis function of V1 is {φ0,k}, where
φ0,k(x) =
√
2φ(2x− k), k ∈ Z
Following the pattern one can continue building spaces:
... ⊂ V−1 ⊂ V0 ⊂ V1 ⊂ V2...
and their basis’s:
φj,k(·) = 2k/2φ(2k · −j), j, k ∈ Z
Since every function in L2(R) can be approximated by a piecewise constant function, it means
that the linear span of the system of functions {{φ0,k}, {φ1,k}, ...} is dense in L2(R). This system
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is not an orthogonal basis in L2(R), but it is possible orthogonalize it. Introducing orthogonal
complement of V0 to V1:
W0 = V1 	 V0 (2.25)
One can see that W0 is the linear subspace of L2(R) spanned by a certain orthogonal basis. The
following function:
ψ(x) =
 −1, x ∈ (0, 1/2]1, x /∈ (1/2, 1] (2.26)
starting the basis in W0, which is the system {ψ0,k} where
ψ0,k = ψ(x− k), k ∈ Z
The graph of Haar functions is presented on Fig.(2.2). We will use names: ”mother wavelet”
for function ψ(·) and ” father wavelet” or ”scaling function” for φ(·). From(2.25) we have V1 =
V0 ⊕W0 the construction can be easily extended to every Vi as:
Vi+1 = Wi ⊕ Vi = V0 ⊕W0 ⊕W1 ⊕ · · · ⊕Wi (2.27)
It is also can be proved that
⋃
i Vi is dense in L2(R), and















where α0k and βjk are coefficients of this expansion.
22
Figure 2.2: Graphs of ψ−1,0 and ψ9,2
2.2.1.2 Mexican Hat Wavelets
In many numerical applications, the orthogonality of the translated dilates ψj,k is not vital. Mexican
Hat wavelet(MHW) is the one of the non orthogonal wavelets. MH originates from the negative ,



















Figure 2.3: Graphs of the MHW functions ψ0,3(t, 1) and ψ9,2(t, 1)
The graph of Mexican Hat Wavelet functions is presented on Fig.(2.3).
2.2.1.3 Wavelet thresholding
Sometimes wavelet estimators may produce a bit of spikes. This reflects the fact that unnecessary
high oscillations are included. Therefore, it is natural to introduce the selection procedure for the
coefficients in wavelet expansion(2.29). Most natural would be to suppress the smallest coefficient
by introducing a threshold. There are several thresholdning procedures, the most common among
them are two: the soft and the hard thresholdings.
• Soft thresholding is when we are replacing all βjk in(2.29) by:
β̂Sjk = (|β̂jk| − t)+ sign(β̂jk) (2.31)
where t is some threshold. This estimator has also name:wavelet shrinkage estimator.
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• Hard thresholding is when we are replacing all βjk in(2.29) by:
β̂Hjk = β̂jkI{|β̂jk| > t} (2.32)
The common problem of thresholding is how to chose a proper value of threshold t ([26]). The
threshold t must be chosen just above the maximum level of noise. Assuming the Gaussian white
noise with variance σ2, it can be proved that the maximum amplitude of the noise has a very high




, where N is the number of coefficients. The fact that the threshold increases with N is due to the
tail of Gaussian distribution and the increasing of the amplitudes of the coefficients for large values
of N .
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CHAPTER 3: METHODS AND RESULTS
3.1 Regularization
Consider regression problem
y = Xβ (3.1)
where X ∈ Rn×m is a design matrix, y ∈ Rn is the data we want to fit and β ∈ Rm is the vector of
coefficients. The solution is the well known least square estimatorβ̂ and is given by:
β̂ = (XTX)−1XTy
It is also known (see, e.g., [36]) that E(β̂) = β and Cov(β̂) = σ2(XTX)−1, thus
E||β̂||2 = ||β||2 + σ2(XTX)−1.
Therefore, in the case of ill-conditioned XTX one will have inflated estimation error, and as con-
sequence, the poor prediction properties. There are several methods of regularization designed to
mitigate the problem, from which we will consider Ridge regression and Lasso.
3.1.1 Ridge Regression
Ridge regression has been used as an alternative estimation method in multiple linear regression
models when there is multicollinearity among the covariates. With the multicollinearity, the ridge
type estimator is suggested because it has a smaller total mean square error (MSE) than the max-
imum likelihood estimator. When the multicollinearity is large, the reduction in MSE can be
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significant. The ridge regression estimator was first proposed by Hoerl and Kennard [17] who
















= (XTX + λI)−1XTy
The ”ridge” addition to the diagonal of XTX clearly reduces the high conditional numbers of the
matrix XTX. It can be proved( see, e.g., [36] or [14]) that the quantity XTX+λI is always invertable
and there is always a unique solution β̂
ridge
. Introducing the linear estimator:
Hridge = X(XTX + λI)−1XT
which is analogous to ”hat” matrix in ordinary regression, the degrees of freedom can be defined
as df = Tr(Hridge). The degrees of freedom df are used in calculation of the Akaike information
criterion (AIC).
AIC = n log(RSS) + 2df
the minimum of which helps to choose the value of λ.
The question now is how to apply the formalism above to our case of time-dependent Cox log-
likelihood? Ridge regression is a special case of the penalized likelihood approach was studied by
Huang and Harrington [19]. The most elegant solution is to use the following trick from [38]. Con-
sider the following Cholesky decomposition of the negative second derivative of the log-likelihood:
∇2l(β) = XTX (3.3)
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where∇ = − ∂
∂β
and ∇2 = − ∂
∂β∂βT
and set up the pseudo response vector:


















where X and Y are understood in terms of (3.3) and (3.4). That method can be applied not only to
ridge but also to another types of penalties. The next problem is the selection of the thresholding
parameter λ.
3.1.2 Lasso
By the Cox proportional hazards model, the hazard function for the patient i is given as
λi(t) = λ0(t) exp(x
T
i β)










where Ri is the set of indices of the patients in the risk set at time ti. For the cases that impose
serious collinearity problem, instead of maximizing the partial likelihood directly, Tibshirani [33]
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proposed to estimate β under the L1-constraint subject to ||β||1 ≤ s:
β̂ = arg max l(β)
or, equivalently by the Lagrange multiplier version:
β̂ = arg min{−l(β) + λ||β||1} with λ > 0.
for λ > 0 .
We will consider in detail the shooting algorithm for lasso, reported first by Fu [11] The description
will follows the lines of the tutorial of Pendse [29] Since we are able to reduce the log-likelihood
optimization problem to the least squares problem (see equations (3.4) and (3.5)). Without loss of




||y− Xβ||22 + λ||β||1 (3.6)
Denote textbfX = [x1, · · · , xp] , β = [β1, · · · , βp], X(−i) = [x1, · · · , xi−1, xi+1, . . . , xp] and





||y− Xβ||22 + λ||β||1 =
1
2
||yi − xiβi||22 + λ||β(−i)||1 + λ|βi|
Replace problem (3.6)by the series of one-dimensional optimization problems (3.7) and carry out











3.2 Denoising and optimization
Another application of FDA which was under study in current work, is the low rank tensor de-
noising. The recent progress in technology has made possible a multitude of novel applications,
which typically require large amount of multidimensional data, such as large-scale images, 3D
video sequences, and neuroimaging data (see, e.g., [4], [32]). To match the data dimensionality,
tensors (also called multiway arrays) have been proven to be a natural and efficient representation
for such massive data. There is a difficulty in a regression setup, of treating the clinical outcome
as a response and treating images as the covariates. Indeed, classical regression methods use co-
variates presented in a vector form. Naively turning an image array into a vector is clearly an
unsatisfactory solution. For instance, (see, e.g., [39]), with a typical anatomical MRI image of size
256 × 256 × 256, it implicitly requires 2563 = 16, 777, 216 regression parameters. Both com-
putability and theoretical properties of the classical regression models are compromised by this
ultra-high dimensionality. It is natural to attempt the solutions which adpplies the FDA (see, e.g.,f
Reiss and Ogden [30] )
Our study is motivated by the analysis of Dynamic Contrast medical imaging data when one has
to observe time changes of some organ recorded as a series of images. From mathematical point
of view this problem can be viewed as a tensor recovery problem (see, e.g., [32]) for an extensive
description. We will follow notation, from [12] which also contains an appropriate algorithm for
the problem in hand.
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3.3 Study of gender and age-specific survival rates
3.3.1 Wavelet model for hazard and survival function
The objective of our research is to check a hypothesis that the hazard functions for male and female
cancer patients differs from each other, depending on the ages of the individuals. It is well known
that probability of survival decreases when one’s age increases, however, this general phenomenon
may not be valid for relatively young individuals in the presence of a life-threatening disease like
lung cancer. We attempt to use wavelets to separate time-dependent part of the hazard function is
(2.13).
Wavelets have been successfully applied in the areas of signal and image processing, physics, etc.
They also proved to be useful in nonparametric statistics (see, e.g. [1]:[3]) The known advantage
of using wavelet basis versus other type of bases is that it accommodates jump discontinuities in
the underlying function. Wavelets allow one to investigate behaviour of a spatially inhomogeneous
function without any assumptions on the size or location of the intervals of smooth (or stable)
behaviour.
Using Haar wavelet basis, generated by a scaling function φ(x) given by equation (2.24) and by
shifts and dilations of the mother wavelet ψ(x) given by equation (2.26), we obtain:
ψjk(x) = 2
j/2ψ(2jx− k), j = 0, 1, ...,∞,
k = 0, 1, ..., 2j−1; x ∈ [0, 1] (3.8)
In order to use wavelet basis for representation of a function, one has to scale the argument of the
function to the interval (0, 1). For example, if we considered survival times of patients at ages
between 40 and 75 , so that (t/12 +Ai) ∈ (0, 1), we need to scale t/12 +Ai to (0, 1) by applying
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transformation
x = [t/12 + Ai − 40]/35.
Here Ai is the age of ith patient. In order to account for time-independent covariates as well as for
dependence of the hazard rate on the current age of individual, we represented individual hazard
functions as
hi(t) = h0(t) exp(f(
t
12
+ Ai)) exp(~Xi~β) (3.9)
where Ai the age of individual i at the time of diagnosis, t is survival time in months, ~Xi is the row
vector of time independent covariates of an individual i and ~β is a column vector of coefficients.
Note that t
12
+ Ai is the age of individual i when his survival time is t months, so that function
f( t
12
+Ai) represents the relationship between survival time and current age of a patient. Since, the
functional form of f(·) is unknown, we estimate function f(·) non-parametrically. In particular, to
take advantage of both modern techniques of non parametric statistics and software which allows
to estimate coefficients in the Cox regression model (2.12), we represent f(·) using wavelet basis.
Using wavelet basis (3.8) and equation(2.29), any function f(x) can be written as






however, since the resolution of the data is limited, one usually applies






where J is the maximum resolution level. The average survival time for our patients was 28 months.
Based on this, we have chosen J = 4, which gives us 31 time dependent coefficients.
Cox model is very popular also because of its simplicity - the time dependent parts of the hazard
function are canceled from the partial likelihood. However, using the two dimensional time vari-
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able allows us to keep them. We will illustrate that with a simple example. Consider an artificial
sample of data:
Table 3.1: Artificial Data for time dependent likelihood













= exp (β · X(T ))
Here T is the current age of the patient. Then the partial likelihood can be easily written as:
L(β) =
exp (β · X(51))
exp (β · X(51)) + exp (β · X(46)) + exp (β · X(62)) + exp (β · X(52)) + exp (β · X(51))
·
exp (β · X(47))
exp (β · X(47)) + exp (β · X(63)) + exp (β · X(53)) + exp (β · X(52))
·
exp (β · X(56))
exp (β · X(56)) + exp (β · X(55)))
It is clear that there are no cancellation of time-dependent functions.
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3.3.2 Data description
For the project we used partial records from the Florida cancer data base. The data base contains
data for cancer patients in the state of Florida between years 1986 and 2005. The lung cancer
patients data contains almost 220,000 records. For the sake of privacy we only used information
about age at diagnosis, stage and type of cancer, smoking patterns and treatment information for
each of the patients. The age distribution of the patients is shown in the Figure3.1.
Figure 3.1: Overall age distribution of cancer patients
One can see that the distribution is heavily biased toward upper ages: 60-80 years old. Since our
goal is to study survival of women of menopausal age (40−61 y.o.), we restricted our studies to the
ages 35-65 years old which left us with 82049 cases from which 35858 records are for women and
46189 records are for men. The rationale for this data reduction is that survival patterns in children
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and young adults and old people differ significantly from those for mature adults. In the course of
the data analysis, we discovered that survival patterns vary greatly with the type of cancer.Type of
cancer was encoded using ”Histology” variable denoted asHi, i = 1 · · · 8. In the course of the data
analysis, we discovered that survival patterns vary greatly for the earlier (Stages 0, 1 and 2) and
the later (Stages 3-9) of cancer and they depend on the type (histology) of cancer as well. Thus,
from the start we have split out data into four categoriess:
• Early Stages, females - 8943 records.
• Earlier stages, males - 9448 records.
• Advanced Stages, females - 26915 records
• Advanced Stages, males - 36741 records
3.3.3 Preliminary results
To simplify analysis we’ve introduced new categorical variable ”AgeGrade” with the help of which
we divided patients onto 8 groups according age of diagnostics. The coding details are given in the
Table 3.2.
At early phase of analysis we fit Cox proportional hazards model with the help of proprietary
software SPSS, using the following model:
SurvMonths = SurvMonths[Status = Dead](Race,Age, Y Birth, Stage, Tobacco, AgeGrade)
The Chi-square value is 8650 for 6 degrees of freedom which makes the p-value close to zero
which also indicates the validity of assumptions of the Cox model. We have plotted cumulative
hazards for all for groups of patients separated by age groups (see Figures 3.3, 3.4, 3.5, 3.6) . For
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earlier stages of cancer, the dependance on age is pretty regular and intuitive, with the exception
that the 4th age group patients ( ages 45-50) have higher survival probability than 3d age group
( ages 40-45) for both sexes. Taking age group 1 (age 35) out from consideration the following
dependence of the cumulative hazards on age is observed for both sexes:
2 < 4 < 3 < 5 < 6 < 7
Figure 3.2: Distribution according type of cancer
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Table 3.2: Age groups coding
Coding Age of Diagnostics
Age grade1 age ≤ 35
Age grade2 35 < age ≤ 40
Age grade3 40 < age ≤ 45
Age grade4 45 < age ≤ 50
Age grade5 50 < age ≤ 55
Age grade6 55 < age ≤ 60
Age grade7 60 < age ≤ 65
As for advanced stages of cancer (Stages 3-9), one can see that contrary to common understanding
of hazard rate increasing with age female patients show quite irregular dependence on age, but
male patiens show the same pattern as for earlier stages. (see Figures 3.5 and 3.6 below). The list
of age groups ordered according to increasing hazard rate for females:
3 < 2 < 6 < 5 < 4 < 7
and for males:
2 < 4 < 3 < 5 < 6 < 7
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Figure 3.3: Hazard For Early Stages of Cancer (females)
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Figure 3.4: Hazard For Early Stages of Cancer (males)
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Figure 3.5: Hazard For Advanced Stages of Cancer(F)
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]
Figure 3.6: Hazard For Advanced Stages of Cancer(M)
The coding is decrypted in the Table 3.3. The distribution of patients according to the type of
cancer is shown in the Figure 3.2. The majority of data corresponds to cancer types: H6(35%),
H5(25%), H1(18%) and H8(16%) or together for 94% of all data.
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Table 3.3: Types of cancer and their code names
Coding Type of Cancer








The graphs of cumulative hazard rates have one thing in common: each curve has the negative
second derivative. Since hazard function is just the derivative of corresponding cumulative hazard,
hazard function is decreasing. Since hazard can’t be negative, the safe assumption would be that
there exists a limiting value of hazard which can be different for each age group. Based on this
heuristic arguments, we have a justification for fitting the right end of the cumulative hazard graph
with a linear function. The left side of each graph of a cumulative hazard function is increasing
fast initially with the rate of growth decreasing afterwards. For this reason, the following approach
was employed: cumulative hazard function was fit with a linear function for the larger survival
times and with a Michaelis-Menten function of the form ( c·t
d+t
) for the smaller times. Therefore we
fit the cumulative hazard function by Λ(t) of the following form:
Λ(t) =

a · t+ b, if t ≤ tst
c·t
d+t
, if t > tst
(3.12)
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There is the additional rationale behind choosing the Michaelis-Menten function for fitting: the
equation of Michaelis-Menten is the basic equation of the enzymatic kinetics. It describes the
dependence of the rate of catalyzed reaction on the concentration of the substrate. That equation
has two parameters: the saturation value - which we call ”assumed cumulative hazard”, and ”half-
way” constant which we call ”the critical time” and interpret as the time which it takes to decrease
the mortality rate from the initial value to some saturated value, which is more descriptive for the
advanced stages of cancer.
Fitting the cumulative hazard function by Λ(t) allows us to estimate the critical time at which
survival patterns change as well as the parameters of the survival time. The fitting is carried out
using the least squares and produces very accurate results for all types of cancer and for all age
groups. See the Figure(3.3.3) The very first look on the results reveals the basic features of the
survival. Females have in general lower values of hazard than males. The transition process is
more abrupt in the case of advanced cancer that in earlier stages. Somehow counter intuitive
results indicates that saturated hazard rate is higher for earlier stages, while assumed cumulative
hazard shows the opposite tendency. The ”critical time” parameter appears to indicate the duration
of the renewal process and it is in inverse relations with a risk to die. For advanced stages it is
about one year and 3-4 years for early stages.
The survival patterns differ significantly for the types of cancer but is is hard to see any gender
related differences so far.
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Figure 3.7: Cumulative hazard rate function fit for the squamous cell carcinoma patients. Left:
Early Stages. Right: Advanced Stages. Top: Females. Bottom: Males.
3.3.4 Results of the analysis using the time-varying Cox regression model.
Since the advanced stages of lung cancer are associated with the very short survival time, we
restricted our attention to patients who have stages 1 or 2 of cancer. This operation left us with
Table 3.4: Results of fit of squamous cell carcinoma patients
Gender Stage a · 10−4 critical time assumed cum.hazard
F. Early 9.95 44.3 0.75
F. Advanced 8.25 13.5 0.82
M. Early 10.76 37.8 0.80
M. Advanced 8.56 12.7 0.85
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only 26% of the original data (57147 of the 219685 records).
We also separated our data according to the sex and the type of cancer. In the dissertation we
are presenting three most common cancer types: Neuroendocrine/small cell carcinoma(H1), Squa-
mous cell carcinoma (H5) and Adenocarcinoma (H6).













where HaarPsi(·) is given by formula (3.8). We have generated vectors of functional values for
all 6 categories and then Cox proportional hazard regression was carried out. That procedure let
us have estimations of coefficients βj,k. After removing non significant coefficients the hazard
functions were reconstructed. The results are shown in the Tables (3.4-3.9).
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Figure 3.8: Hazard of squamous cell carcinoma patients. Left: Early Stages. Right: Advanced
Stages. Top: Females. Bottom: Males.
Table 3.5: Wavelet coefficients for female patients of Neuroendocrine/small cell carcinoma
Earlier Advanced
β Value Ages covered β Value Ages covered
β3,1 -0.267 (42 · · · 48) β1,0 -0.093 (36 · · · 60)
β4,6 0.183 (54 · · · 57) β3,2 -.090 (48 · · · 54)
β4,10 0.521 (66 · · · 69) β3,4 -0.071 (60 · · · 66)
β5,10 -0.517 (51 · · · 52.5) β4,1 -0.262 (39 · · · 42)
β5,23 0.990 (70.5 · · · 72) β4,2 -0.355 (42 · · · 45)
β4,3 -0.157 (45 · · · 48)
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Figure 3.9: Haar wavelets fit of time dependent part of hazard function of Neuroendocrine/small
cell carcinoma patients. Left: Early Stages. Right: Advanced Stages
Table 3.6: Wavelet coefficients for male patients of Neuroendocrine/small cell carcinoma
Earlier Advanced
β Value Ages covered β Value Ages covered
β2,1 -0.195 (48 · · · 60) β1,0 -.075 (36 · · · 60)
β4,4 -0.554 (48 · · · 51) β2,0 -.128 (36 · · · 48)
β4,5 -0.286 (51 · · · 54) β4,9 0.065 (63 · · · 66)
β4,9 -0.168 (63 · · · 66) β4,12 -0.572 (72 · · · 75)
β5,1 -0.989 (37.5 · · · 39) β5,6 0.257 (45 · · · 46.6)
β5,6 0.579 (45 · · · 46.6)
β5,8 -0.988 (48 · · · 49.6)
β5,10 -0.533 (51 · · · 52.5)
β5,20 -0.485 (66 · · · 67.5)
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Table 3.7: Wavelet coefficients for female patients of Squamous cell carcinoma
Earlier Advanced
β Value Ages covered β Value Ages covered
β2,1 .140 (48 · · · 60) β3,0 .530 (36 · · · 42)
β2,2 .160 (60 · · · 72) β4,11 .376 (69 · · · 72)
β3,5 .250 (66 · · · 72) β5,10 -.216 (51 · · · 52.5)
β5,13 -.194 (55.5 · · · 57) β5,14 .125 (57 · · · 58.5)
β5,22 -.435 (69 · · · 70.5) β5,15 .137 (58.5 · · · 60)
β5,25 .638 (73.5 · · · 75) β5,19 .109 (64.5 · · · 66)
Table 3.8: Wavelet coefficients for male patients of Squamous cell carcinoma
Earlier Advanced
β Value Ages covered β Value Ages covered
β2,2 -.145 (60 · · · 72) β2,2 -.147 (60 · · · 72)
β3,1 -.213 (42 · · · 48) β3,3 -.037 (54 · · · 60)
β3,4 -.049 (60 · · · 66) β4,3 -.101 (45 · · · 48)
β3,5 -.153 (66 · · · 72) β4,5 .068 (51 · · · 54)
β4,8 .071 (60 · · · 63) β4,12 .510 (72 · · · 75)
β4,10 -.171 (66 · · · 69) β5,6 -.173 (45 · · · 46.5)
β5,14 -.096 (57 · · · 58.5)
β5,26 .629 (75 · · · 76.5)
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Figure 3.10: : Haar wavelets fit of time dependent part of hazard function of squamous cell carci-
noma patients. Left: Early Stages. Right: Advanced Stages
Table 3.9: Wavelet coefficients for female patients of Adenocarcinoma
Earlier Advanced
β Value Ages covered β Value Ages covered
β3,3 -.099 (54 · · · 60) β2,1 -.036 (48 · · · 60)
β3,4 -.138 (60 · · · 66) β3,1 -.070 (42 · · · 48)
β4,4 .253 (48 · · · 51) β4,11 .355 (69 · · · 72)
β4,9 -.085 (63 · · · 66) β5,11 -.124 (52.5 · · · 54)
β4,10 .114 (66 · · · 69) β5,13 .093 (55.5 · · · 57)
β5,2 1.254 (39 · · · 40.5) β5,22 .236 (69 · · · 70.5)
β5,12 -.283 (54 · · · 55.5) β5,25 -.721 (73.5 · · · 75)
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Figure 3.11: : Haar wavelets fit of time dependent part of hazard function of Adenocarcinoma
patients. Left: Early Stages. Right: Advanced Stages
Table 3.10: Wavelet coefficients for male patients of of Adenocarcinoma
Earlier Advanced
β Value Ages covered β Value Ages covered
β4,8 -.101 (60 · · · 63) β1,0 -.052 (36 · · · 60)
β4,11 .300 (69 · · · 72) β2,1 -.030 (48 · · · 60)
β5,12 -.187 (54 · · · 55.5) β4,1 -.213 (39 · · · 42)
β5,14 -.164 (57 · · · 58.5) β4,2 -.131 (42 · · · 45)
β5,15 -.165 (58.5 · · · 60) β4,4 -.066 (48 · · · 51)
β5,21 -.376 (67.5 · · · 69) β4,12 .572 (72 · · · 75)
β5,26 -.586 (75 · · · 76.5) β5,12 .123 (54 · · · 55.5)
β5,27 .706 (76.5 · · · 78) β5,16 .069 (60 · · · 61.5)
Since the wavelet coefficients are time dependent, the computation of Cox regression appears to
be involved. The attempt to use already available software was successful for Haar wavelets. We
used SPSS feature of introducing time-dependent covariates into the model. The attempt to do the
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same with the Mexican Hat wavelets which are more appealing for Functional Data Analysis was
not successful - since Mexican Hat wavelets are not orthogonal, we have encountered situation of
highly correlated variables which leads to crashing of the algorithm. The problem can be avoided
by using some kind of regularization. We were using two types of regularization: the ridge (L2
penalty) and the lasso (L1 penalty).
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3.3.4.1 The ridge penalty
Algorithm 1 L2 penalized Cox regression
β = initial β0 and ε = 0.001
while ||βi+1 − βi|| > ε do
calculate l; ∇ = − ∂l
∂β
; ∇2 = − ∂2l
∂β∂βT








βi+1 ← (XTX + λI)−1XTY
end while
The algorithm of the ridge regression can be summarized as follows- see Algorithm 1.
3.3.4.2 The lasso penalty
The lasso [33] is a regularized estimation approach that constrains the L1 norm of coefficient
vector. Instead of the log-likelihood we deal with its penalized version:




where the first term is the log-likelihood which is concave and twice differentiable. Thee second
term, the penalty, is concave and continuous but is not differentiable at points where βi = 0. To
avoid that difficulty, we follow the idea of Goeman [13]. Consider directional vector v ∈ Rp and
the corresponding derivative:
l′pen(β, v) = lim
t→0
(lpen(β + tv)− lpen(β)) (3.14)
52
That gradient can be defined for every β as the scaled direction of the steepest ascent.
gi(β) =

Gi(β)− λsign(βi) if βi 6= 0
Gi(β)− λsign(Gi(β)) if βi = 0 and |Gi(β)| > λ
0 otherwise
(3.15)
where Gi(β) is the ith component of the gradient of the non-penalized log-likelihood given in
equation (2.15). The gradient is ,therefore, discontinuous at every point where βi = 0. The second
derivative of the penalized log likelihood can also can be understood in terms of the quadratic form
of non penalized log likelihood:
l′′pen(β, v) = v
′Hv (3.16)
where components of the matrix H are given by equation (2.16).
Consider second order Taylor approximation in the direction of the gradient (3.15) given by:




One needs to understand that the equation above has a meaning only within a subdomain of conti-






: sign βi = − sign gi(β) 6= 0
}





we only can accept topt if it is smaller than tedge The update for β then proceed as follows:
βi+1 = βi + min(topt, tedge)g(βi) (3.18)
The algorithm described by equation(3.18)does not involve computational expensive operations
such as matrix inversion, but requires a large number of iterations for convergence. For us it
is undesirable because we need to calculate time-dependent likelihood which is computationally
expensive process. Therefore the update in the work of Goeman [13] was beneficial for us. Goeman
proposed to use Newton-Raphson algorithm, which is known for its fast convergence rate, and to
switch to update described by equation(3.18) when Newton-Raphson step has failed.
Algorithm 2 L1 penalized Cox regression
β = initial β0 and ε = 0.001
while ||βi+1 − βi|| > ε do
calculate l; G = ∂l
∂β




Gi(β)− λsign(βi) if βi 6= 0
Gi(β)− λsign(Gi(β)) if βi = 0 and |Gi(β)| > λ
0 otherwise




calculate topt = −
l′pen(β,g(β))
l′′pen(β,g(β))




: sign βi = − sign gi(β) 6= 0
}
βi+1 ← βi + min(topt, tedge)g(βi)
end while
The results are presented on the Figures 3.13-3.15. There are no informative patterns regarding
advanced stages of cancer. But for the earlier stages we can see quite distinct maximum in the
hazard rate for female patients comparing to male patients for all types of cancer presented. The
absolute value therefore is not large. This is the explanation why it was to hard to show the
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dependence of the hazard rate on age. The values at maximum of hazard rates for female patients
vary from 0.01 for small cell carcinoma to 0.04 for Squamous cell carcinoma and up to to 0.1 for
Adenocarcinoma. Whether the change in hazard rates is due to menopause or not is not possible
to state based just on statistical data, but definitely there is exist some king of dependence and we
provided evidence for deeper investigations of the phenomena.
Figure 3.12: : Current age dependent part of hazard function for early (left) and advanced (right)
stages of Squamous cell carcinoma
Figure 3.13: : Current age dependent part of hazard function for early (left) and advanced (right)
stages of Neuroendocrine/small cell carcinoma
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Figure 3.14: : Current age dependent part of hazard function for early (left) and advanced (right)
stages of Adenocarcinoma
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CHAPTER 4: ESTIMATION OF MATRIX-VARIATE FUNCTION.
4.1 Introduction
In vivo optical imaging exploits contrasts agents which interact with visible and near-infrared
wavelengths in living tissues. Compared with another types of imaging like X-ray and magnetic
resonance imaging (MRI), optical imaging has the major benefit of being able to exploit a rich
palette of contrasts. Recently, considerable progress was achieved with Dynamic Contrast En-
hanced (DCE) imaging. This method is used intensively in brain science and oncology. DCE has
a great potential for cancer detection and characterization as well as for monitoring in vivo the
effects of treatments.
The penetration of the contrast agent in living tissue is defined either by passive transport ( dif-
fusion) or active transport mechanisms. In each particular case the dynamic of contrast can shine
light on deep internal cell processes and pathways such as receptor activity, antigen expression,
endocytosis etc, see e.g. [35], [27], [22]. Intuitively it is clear that the change in the amount of
contrast agent over time can be described by a continuous function, which opens opportunity for
Functional Data Analysis methods. Consider the problem of estimation of a smooth matrix-variate
function f : [a, b]→ Rm1×m2 on the basis of its discrete noisy measurements
Yi = f(ti) + εξi, Yi, fi, ξi ∈ Rm1×m2 , i = 1, · · · , n. (4.1)
Here, ξi are i.i.d. with matrix-variate normal distribution N(0, Im1 × Im2) and function f is such
that each of its components is a smooth function and, for each ti, matrices f(ti) have low ranks.
The objective is to recover the matrix-variate function f . Since observations Yi, i = 1, · · · , n,
form a tensor, problem of estimating f is the problem of recovery of a sparse tensor from its noisy
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observations. Denoting the 3-dimensional tensors of observations, values of function of interest
and errors by Y , f and ξ, respectively, obtain the following model
Y = f + εξ. (4.2)
In the literature, there have been roughly three categories of solutions to establishing association
between matrix/array covariates and clinical outcome [18]
1 Voxel-based methods, which take the image data at each voxel as responses and clinical
variables such as age and gender as predictors, and then generate a statistical parametric map
of test statistics or p-values across all voxels. Since the relationship between the correlation
of voxels is not taken into consideration, this method we will not explore father.
2 FDA wa takes a one-dimensional function as predictor. Fitting such models commonly in-
volves representing functions as a linear combination of basis functions which are either
pre-specifie, or obtained from principal component decompositions.
3 Two step strategy: carrying out a dimension reduction followed by fitting a model.
Problems like (4.1) appear in image processing, medical imaging and computer vision. For exam-
ple, in the case of Dynamic Contrast Enhanced medical imaging, one obtains a series of matrices
where each of the matrices represents an image at a particular time instance and each of the pixel
represents an amount of the contrast agent in a unit volume of tissue. Since the amount of contrast
agent can only change gradually, each component of the matrix-variate function is itself a smooth
function of time. Each of the images, however, does not necessarily form a smooth function since,
for example, metastases of a tumor usually do not form a smooth continuous structure. Further-
more, since the amounts of contrast agent in a similar tissue types are proportional to each other,
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one expects that many of the time-varying components of f are either equal or proportional to each
other in value.
Due to these similarities, one can expect that if each of the functions is expanded over the same
basis {φj(t), j = 1, 2, · · ·}, the coefficients of the expansion should form low rank matrices with
decreasing norms. For this reason, problem (4.2) is related to both the matrix regression and the
linear regression problem.
4.2 Notations
Below, we provide a brief summary of the notation used throughout this chapter. Let A ∈
Rm1×m2×M be a 3-dimensional tensor and B,B1, B2 ∈ Rm1×m2 be matrices. Denote the k × k
identity matrix by Ik. Denote elements of a matrix B by Bj1,j2 .
• For any vector η ∈ Rp, we denote the standard l1 and l2 vector norms by ‖η‖1 and ‖η‖2,
respectively.
• For any numbers, a and b, denote a ∨ b = max(a, b) and a ∧ b = min(a, b).
• We define the scalar product of matrices 〈B1, B2〉 = Tr(BT1 B2) where Tr(·) denotes the
trace of a square matrix.










with m = m1 ∧m2,
respectively, the trace(nuclear), and Frobenius norms of matrix B. Here σj(B) are the
singular values of B in decresing order. Also, ‖B‖ = σ1(B) is the spectral norm of matrix
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B.












• Denote Kronecker delta function by δk1,k2: δk1,k2 = 1 if k1 = k2, otherwise δk1,k2 = 0.
• For the tensor T ∈ Rl×m×k and the matrix M ∈ Rl×n the tensor O ∈ Rn×m×k is the following
product:




where mi is the ith column of the matrix M and Tiis the ith ”slice” of the tensor T and the
operation follows the following scheme:
1 Unfold tensor T to matrix MT ∈ Rm·k×l
2 Multiply MT and M: MO = MT ·M; MO ∈ Rm·k×n
3 Fold matrix MO into tensor O
In what follows, we use the symbol C for a generic positive constant, which is independent of n,
m1, s and l, and may take different values at different places.
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4.3 Estimation procedure and its risk
Consider a basis {φj(t), j = 1, 2, · · ·} on the interval [a, b]. Expand each of the components of f




Alφl(ti), i = 1, · · · , n, (4.1)
where coefficients Al ∈ Rm1×m2 , l = 1, · · · ,M , are matrices. Consider matrix Φ ∈ RM×n
Φ =

φ1(t1) · · · φ1(tn)
· · · · ·
φM(t1) · · · φM(tn)








. Let f, fA ∈ Rn×m1×m2 and A ∈ RM×m1×m2 be the 3-dimensional tensors of the values of
functions f(t) and fA(t) at points ti, i = 1, · · · , n, and of M matrix coefficients in the expansion
(4.1). Then,




where φl ∈ Rn is the lth column of the matrix Φ. We obtain an estimator Â of A by minimizing

















Âlφl(t), t ∈ [a, b]. (4.3)
and measure the quality of the estimator (4.3) by
R(fÂ = n
−1‖fÂ − f‖2,
the L2 norm of the difference of tensors fÂ and f at points t1, · · · , tn.
In what follows, we assume that f is sparse, so that coefficients Al ∈ Rm1×m2 in (4.1) are the low
rank matrices.
Let L be any subset of the set {1, 2, · · · ,M}. Then, the following oracle inequality holds.
Theorem 1 Let eigenvalues of matrix W be bounded above and below
0 < wmin = σmin(W ) ≤ σmax(W ) = wmax <∞. (4.4)
Let λ ≥ 2 ε√
n
√
2τ log n+ 2 log(m1 +m2) + logM . Then, for any τ > 0, with probability at least
1− 2n−τ one has
1
n


















l∈LAlφl − f‖22 is the bias,
∑




of estimating one value. σmax
σmin
is the conditional number of the basis matrix (if the grid is uniform,
W = 1
n
ΦΦT = I and σmin = σmax = 1). σmax is magnification due to the basis matrix. (2τ log n+
2 log r0) is the log-factor (price for adaptability.
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Proof of Theorem 1. Note that, for any Ã ∈ Rm1×m2×M one has
1
n




































Since Y − f = εξ where ξ ∈ Rm1×m2×M is a tensor with i.i.d. N(0, 1) entries, obtain
〈








































φl(ti)ξi l = 1, · · · ,M, Ξl ∈ Rm1×m2

































φ2l (ti)δj1,j2δk1,k2 = ρ
2
l δj1,j2δk1,k2
Hence, Ξl = ρlZl where Zl is the Rm1×m2 matrix with i.i.d. N(0, 1) entries. Therefore, the
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left-hand side of equation (4.7) can be bounded above as follows

















||Âl − Ãl||1 · ρl max
1≤l≤M
||Zl||.
For any τ > 0,
P (||Zl|| > τ
√


















m1 ∨m2) ≤ n−τ
Hence, with probability at least 1− n−τ one has(see Tropp Ch. 4 [34]):
M∑
l=1
∣∣∣Tr [(Âl − Ãl)TΞl]∣∣∣ ≤ M∑
l=1




2 [log(m1 +m2) + logM + τ log n]
(4.9)
Let Ωl be the set of points where inequality (4.9) is valid. Denote by Ω =
⋂M
l=1 Ωl the set of points
where (4.9) is true for every l. Then, by Morgan laws,
P (Ω) ≥ 1− n−τ (4.10)
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and, for any ω ∈ Ω, one has
2|
〈













2τ log n+ 2 log(m1 +m2) + logM. (4.12)

















‖Âl − Ãl‖1 + ‖Âl‖1 − ‖Ãl‖1
]
.
Let L ⊆ {1, 2, · · · ,M} and Lc be its complement. Let Ãl = 0 if l ∈ Lc. Denote rl = rank(Ã).



















m1 ∨m2‖Âl − Ãl‖1 + λ
√




















m1 ∨m2‖Âl − Al‖1 + λ
√






In order to obtain an upper bound for ∆1, we apply Lemmas 6 and 7 of Rohde and Tsybakov [31]:
Lemma 1 Let matrices A and B have the same size and if ABT = 0; ATB = 0 then
||A+B||1 = ||A||1 + ||B||1 (4.15)
The proof is from Recht, Fazel and Parrilo 2010.[2]
Proof of Lemma 1. Consider the singular value decomposition’s of A and B keeping zero singular
vectors:









The condition ABT = 0 implies that V A1TVB1 = 0, and similarly, ATB = 0 implies that
UTA1UB1 = 0. Hence, there exist matrices UC and VC such that [UA1 UB1 UC ] and [VA1 VB1 VC ] are
orthogonal matrices. Thus, the following are valid singular value decomposition’s for A and B:





 [VA1 VA2 VC ]T
and





 [VB1 VB2 VC ]T
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In particular:




This shows that the singular values of A+B are equal to the union (with repetition) of the singular
values of A and B. Hence,||A+B||∗ = ||A||∗ + ||B||∗ as desired.
Lemma 2 Let A ∈ Rm×T with rank(A) = r and singular value decomposition A = UΛVT . Let
B ∈ Rm×T be arbitrary. Then there exists a decomposition B = B1 + B2 with the following
properties:
a. rank(B1) ≤ 2 rank(A) ≤ 2r.
b. ABT2 = 0; A
TB2 = 0.
c. Tr(BT1 B2) = 0.



















it can be easily verified that B1 and B2 satisfy the conditions of the Lemma.
Therefore according Lemma2 the following is true:




l with the following properties:




T = 0; ÃTl (Â
(2)










2. If matrices B1 and B2 are such that B1BT2 = 0 and B
T

















λ0‖Â(1)l − Ãl‖1 + λ0‖Â
(2)




‖Âl‖1 ≥ ‖Â(2)l + Ãl‖1 − ‖Â
(1)
l − Ãl‖1 = ‖Â
(2)





























ρl‖Â(1)l − Al‖1. (4.17)





























‖Â(1)l − Ãl‖1 ≤
√
2rl‖Âl − Ãl‖2. (4.18)















2rl‖Â(1)l − Al‖2. (4.19)















Âl1 − Ãl1 , Âl2 − Ãl2
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2rl‖Âl − Al‖22 (4.20)




















































































where rl = rank(Ãl). Since Ãl are arbitrary, this completes the proof.
4.4 Algorithm and Simulation results
Workin with a series of medical images i.e. with tensor data can be divided into two approaches:
local and global. A local approach looks at neighboring pixels or voxels of a missing element and
locally estimate the unknown values on basis of some difference measure between the adjacent
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entries. In contrast, a global approach takes advantage of a global property of the data, and is the
path that we use. For matrix-valued data, the rank of a matrix is a good notion of sparsity. As it is
a non-convex function, matrix rank is difficult to minimize in general. Recently, the nuclear norm
was advocated to be used as convex surrogate function for the rank function [3]. Generalizing this
program, a convex surrogate for the tensor rank applied to the unfoldings of the unknown tensor. A
related approach, which penalizes the unfoldings of the solution tensor to have low nuclear norm,
was already presented in [25] for the special case of tensor completion. Gandi et al [12] have
developed very convenient algorithm for solution problems like 4.2. Since the the optimization
problem with low rank penalty is a NP problem, significant work were devoted to find a work
around of this problem which manifested in the brilliant article of Cai, Candes, Shen [20] who
introduced a novel algorithm to approximate the matrix with minimum nuclear norm among all
matrices obeying a set of convex constraints. Thus the problem of a rank minimization may be
understood as the convex relaxation problem.
4.4.1 Douglas-Rachford technique
Douglas-Rachford algorithm [9] is known for more than 50 years, it addresses the minimization of
the sum of two functions (f + g)(x). Where f and g are from a class of all lower semicontinuous
convex functions from a real Hilbert space. To proceed lets consider the following sequence:











where tn ∈ [0, 2] and
∑
n tn(2− tn) =∞, and the proximal map, of index γ ∈ (0,∞) of function
f is given by the following equation:
y = prox [
γ,f










Under certain conditions see e.g [5], [6], the sequence (4.1) converges weakly to the minimizer
of (f + g)(x). To recast our minimization problem given by equation (4.2 to the unconstrained










||A0 ∗ Φ− Y ||22 + ||A1||∗
g(A) = i(A)D =

0, if A ∈ D
+∞, otherwise
(4.3)
This formalizm is equivalent to equation (4.2) , we only need to establish proximity maps of f and

























= shrink(X, τ) (4.5)
The operator shrink(X, τ) acts by applying the soft thresholding to the singular values of X . Con-





where ΣX = diag(σ1(X), · · · , σr(X)) , hence action of ”shrink” operator can be described as:
shrink(X, τ) = UXdiag [max {σ1 − τ} , · · · ,max {σr − τ}]V TX
To apply shrinking operator to a tensor we need to unfold the tensor to matrix first and then upon

























Finally, the proximal map of the indicator function iD is the orthogonal projection onto the set D
and is given by:




Now we can develop splitting Douglas-Rachford algorithm for our problem (4.2)
Algorithm 3 splitting Douglas-Rachford algorithm
input: tensor Y of observed data; functional matrix Φ
input: ti-divergent sequence
input: λ τ γ -parameters for Lagrange multipliers and for soft thresholding
input: ε - to check convergence
Init tensor A(0)0 and A
(0)
1 with zeros
while ||Ai+1 − Ai|| > ε do
Â = mean(A(i)0 + A
(i)
1 )

















We generated some functional data using elementary functions, contaminated them with Gaussian
noise and then recovered the data using algorithm (4.4.1) the functions were evaluated over integer




; x(30− x); x
3
900
; tan x; x log(1 + x)
We created tensor of zeros T ∈ R30×30×30 and randomly inserted functional fibers in it. Then a
random Gaussian noise was added. The results are presented on the Figure [9] below. The nuclear
norm of the ”denoised” tensor is even smaller that the one for the original tensor before addition
of the noise. From another point of view the bias are still significant and for some functions it is
larger than for anothers.
74





• Current Age dependent hazard model We found some evidence that in the case of the Ade-
nocarcinoma and squamous cell carcinoma the hazard increasing for women of ages 52−56
is comparison with men
• Matrix-variate denoising We developed oracle in equality for the matrix-variate data least
squares fit. We also developed algorithm which carries out denoising and delivers optimal
convergence rates.
5.2 Future work
We are planning to continue our investigation in two different direction. One venue is a survival
analysis combined with genetic and biochemical data. There is also possibility of applying renewal
mathematical models together with cancer growth mathematical models toward understanding car-
cinogenics and cancer mortality.
Another direction is father developing algorithm for functional data for Dynamic Contrast En-
chanced imaging. The results obtained can be improved by taking into considerations different
penalty functions including the ones based on metabolic kinetics from one side and on advanced
mathematical conceptions such as fractal dimension for example from another side. There is a
room for improvement: undeniably, however, this is a matter of future investigation.
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